臓器移植市場：タイプ別、エンドユーザー別-2025～2030年の世界予測

臓器移植市場は、2023年に164億5,000万米ドルと評価され、2024年には180億7,000万米ドルに達すると予測され、CAGR 10.30%で成長し、2030年には326億9,000万米ドルに達すると予測されています。

臓器移植市場の範囲と定義には、臓器を体から取り出してレシピエントの体に移植する外科手術が含まれます。糖尿病、心臓病、腎臓病などの慢性疾患の増加により、臓器移植の必要性はますます高まっています。用途別では、心臓移植、肝臓移植、腎臓移植、肺移植、膵臓移植があり、最終用途には病院、移植センター、研究機関などが含まれます。同市場は、臓器不全の有病率の増加、手術技術の進歩、免疫抑制剤の改良、臓器提供に対する意識や取り組みの高まりといった要因から大きな影響を受けています。

最新の潜在的機会は、臓器供給不足と拒絶反応の合併症がもたらす限界に対処する、バイオエンジニアリングや再生医療のような技術的進歩から生じる。臓器保存技術の革新と人工臓器の開発は、有利な道を記載しています。成長が見込まれる市場は臓器拒絶反応のリスク、倫理的懸念、高コスト、厳しい規制の枠組みといった限界に直面しており、これらは依然として課題となっています。さらに、臓器の需要と供給の間の格差は、引き続き市場の拡大を妨げています。

成長機会を活用するため、利害関係者は、臓器供給の拡大が期待できる異種移植や幹細胞治療の革新的研究に注力すべきです。臓器提供者登録制度や社会教育キャンペーンを推進することで、ドナー率を刺激し、市場開拓をさらに後押しすることができます。さらに、免疫抑制レジメンを調整するための個別化医療を探求することで、移植の成功率を高めることができます。結局のところ、市場力学はダイナミックであり、臓器不足に対処し患者の転帰を向上させるための継続的な研究とイノベーションの取り組みが市場を牽引しています。

市場力学：急速に進化する臓器移植市場の主要市場洞察を公開

臓器移植市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネス機会の獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 臓器移植手術件数の増加
  • 慢性疾患の増加と臓器不全の加速化
  • 臓器提供と移植の合法化チャネルの開発
• 市場抑制要因
  • 臓器提供者の不足と治療費の高騰
• 市場機会
  • 臓器移植法の技術的進歩
  • 臓器提供に対する意識の高まり
• 市場課題
  • 臓器移植における社会的・倫理的懸念

ポーターのファイブフォース：臓器移植市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、臓器移植市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォースフレームワークは、企業の競合を評価し、戦略的機会を探るための明確な手法を記載しています。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これら洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：臓器移植市場における外部からの影響の把握

外部マクロ環境要因は、臓器移植市場の業績力学を形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を記載しています。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析：臓器移植市場における競合情勢の把握

臓器移植市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、セグメント化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニングマトリックス：臓器移植市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、臓器移植市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限はベンダーを明確かつ正確に区分し、ユーザーが戦略目標に最適なパートナーやソリューションを特定するのに役立ちます。

本レポートは、主要な注目セグメントを網羅した包括的な市場分析を提供しています。

1.市場の浸透度：産業主要企業の広範なデータを含む、現在の市場環境の詳細なレビュー。

2.市場の開拓度：新興市場における成長機会を特定し、既存セグメントにおける拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを記載しています。

3.市場の多様化：最近の製品発売、未開拓の地域、産業の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発とイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています。

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、地域はどこか？

3.市場を形成する主要技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 臓器移植手術件数の増加
    • 慢性疾患の増加と臓器不全の増加
    • 臓器提供と移植のための合法的なチャネルの開発
  • 抑制要因
    • 臓器提供者の不足と治療費の高騰
  • 機会
    • 臓器移植手法における技術的進歩
    • 臓器提供への意識向上
  • 課題
    • 臓器移植における社会的と倫理的懸念
• 市場セグメンテーション分析
  • タイプ：腎臓疾患の増加により腎臓移植が急増
  • エンドユーザー：スタッフと技術の専門化により移植センターの臓器移植が進化
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治
  • 経済
  • 社会
  • 技術
  • 法律
  • 環境
• 顧客のカスタマイズ

第6章 臓器移植市場：タイプ別

• イントロダクション
• 心臓移植
• 腎臓移植
• 肝臓移植
• 肺移植
• 膵臓移植

第7章 臓器移植市場：エンドユーザー別

• イントロダクション
• 病院と介護サービス提供者
• 移植センター

第8章 南北アメリカの臓器移植市場

• イントロダクション
• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋の臓器移植市場

• イントロダクション
• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカの臓器移植市場

• イントロダクション
• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
  • TransMedicsがSummit Aviationを買収する正式契約を締結し、TransMedicsの航空能力を臓器移植向けに拡大
  • LiveOnNYとMediGOが協力し、臓器提供と移植エコシステム内の透明性と説明責任を高めるリアルタイム臓器追跡技術を発表
  • PAHOとスペイン、南北アメリカにおける臓器提供と移植の強化に関する協定に署名

企業一覧

• Illumina, Inc.
• Veloxis Pharmaceuticals, Inc. by Asahi Kasei Corp.
• Artivion, Inc.
• Thermo Fisher Scientific Inc.
• Pfizer Inc.
• OrganOx Limited
• Organovo Holdings, Inc.
• Arthrex, Inc.
• 21st Century Medicine
• Exactech, Inc.
• CHIESI Farmaceutici S.p.A. by Amryt Pharma PLC
• Xvivo Perfusion AB
• Sanofi S.A.
• BiolifeSolutions, Inc.
• Dr. Franz Kohler Chemie GmbH
• Teva Pharmaceuticals Industries Ltd.
• Preservation Solutions, Inc.
• F. Hoffmann-La Roche Ltd
• Organ Recovery Systems
• Medtronic PLC
• Astellas Pharma Inc.
• Stryker Corporation
• Novartis AG
• NHS Blood and Transplant
• TransMedics Group, Inc.
• Plexision
• AbbVie Inc.
• Bio-Rad Laboratories, Inc.

LIST OF FIGURES

• FIGURE 1. ORGAN TRANSPLANTATION MARKET RESEARCH PROCESS
• FIGURE 2. ORGAN TRANSPLANTATION MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS ORGAN TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS ORGAN TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES ORGAN TRANSPLANTATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES ORGAN TRANSPLANTATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC ORGAN TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC ORGAN TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ORGAN TRANSPLANTATION MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. ORGAN TRANSPLANTATION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. ORGAN TRANSPLANTATION MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. ORGAN TRANSPLANTATION MARKET DYNAMICS
• TABLE 7. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY HEART TRANSPLANTATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY KIDNEY TRANSPLANTATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY LIVER TRANSPLANTATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY LUNG TRANSPLANTATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY PANCREAS TRANSPLANTATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY HOSPITALS & CARE PROVIDERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL ORGAN TRANSPLANTATION MARKET SIZE, BY TRANSPLANT CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. AMERICAS ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 17. AMERICAS ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS ORGAN TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 19. ARGENTINA ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 20. ARGENTINA ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 21. BRAZIL ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 22. BRAZIL ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 23. CANADA ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 24. CANADA ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 25. MEXICO ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 26. MEXICO ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 27. UNITED STATES ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 28. UNITED STATES ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 29. UNITED STATES ORGAN TRANSPLANTATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 30. ASIA-PACIFIC ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 31. ASIA-PACIFIC ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 32. ASIA-PACIFIC ORGAN TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 33. AUSTRALIA ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 34. AUSTRALIA ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 35. CHINA ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 36. CHINA ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 37. INDIA ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 38. INDIA ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 39. INDONESIA ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 40. INDONESIA ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 41. JAPAN ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 42. JAPAN ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 43. MALAYSIA ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 44. MALAYSIA ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 45. PHILIPPINES ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 46. PHILIPPINES ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 47. SINGAPORE ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 48. SINGAPORE ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 49. SOUTH KOREA ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 50. SOUTH KOREA ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 51. TAIWAN ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 52. TAIWAN ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 53. THAILAND ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 54. THAILAND ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 55. VIETNAM ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 56. VIETNAM ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 57. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 58. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 59. EUROPE, MIDDLE EAST & AFRICA ORGAN TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 60. DENMARK ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 61. DENMARK ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 62. EGYPT ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 63. EGYPT ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 64. FINLAND ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 65. FINLAND ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 66. FRANCE ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 67. FRANCE ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 68. GERMANY ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 69. GERMANY ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 70. ISRAEL ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 71. ISRAEL ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 72. ITALY ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 73. ITALY ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 74. NETHERLANDS ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 75. NETHERLANDS ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 76. NIGERIA ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 77. NIGERIA ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 78. NORWAY ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 79. NORWAY ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 80. POLAND ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 81. POLAND ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 82. QATAR ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 83. QATAR ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 84. RUSSIA ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 85. RUSSIA ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 86. SAUDI ARABIA ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 87. SAUDI ARABIA ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 88. SOUTH AFRICA ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 89. SOUTH AFRICA ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 90. SPAIN ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 91. SPAIN ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 92. SWEDEN ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 93. SWEDEN ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 94. SWITZERLAND ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 95. SWITZERLAND ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 96. TURKEY ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 97. TURKEY ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 98. UNITED ARAB EMIRATES ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 99. UNITED ARAB EMIRATES ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 100. UNITED KINGDOM ORGAN TRANSPLANTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 101. UNITED KINGDOM ORGAN TRANSPLANTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 102. ORGAN TRANSPLANTATION MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 103. ORGAN TRANSPLANTATION MARKET, FPNV POSITIONING MATRIX, 2023

The Organ Transplantation Market was valued at USD 16.45 billion in 2023, expected to reach USD 18.07 billion in 2024, and is projected to grow at a CAGR of 10.30%, to USD 32.69 billion by 2030.

The scope and definition of the organ transplantation market encompass the surgical procedure where an organ is removed from one body and placed in the body of a recipient, often necessitated by the failure or non-functionality of the recipient's organ. The necessity of organ transplantation is increasingly critical due to rising incidences of chronic diseases like diabetes, heart disease, and kidney disorders, which often require such interventions. Application-wise, it spans heart, liver, kidney, lung, and pancreas transplants, with end-use scope including hospitals, transplant centers, and research organizations. The market is significantly influenced by factors such as the growing prevalence of organ failure, advancements in surgical techniques, improved immunosuppressive drugs, and increasing awareness and initiatives towards organ donation.

Latest potential opportunities arise from technological advancements like bioengineering and regenerative medicine, addressing the limitations posed by organ supply shortages and rejection complications. Innovation in organ preservation techniques and development of artificial organs offers lucrative avenues. Despite the growth prospects, the market faces limitations such as organ rejection risks, ethical concerns, high costs, and stringent regulatory frameworks, which remain challenging factors. Furthermore, the disparity between organ demand and supply continues to hinder market expansion.

To harness growth opportunities, stakeholders should focus on innovative research in xenotransplantation and stem cell therapy, which hold promise for extending the organ supply. Advancing organ donor registration systems and public education campaigns can stimulate donor rates, further supporting market development. Additionally, exploring personalized medicine to tailor immunosuppressive regimens can enhance transplantation success rates. Ultimately, the organ transplantation market is dynamic and driven by continuous research and innovation efforts to address organ scarcity and enhance patient outcomes, indicating a significant potential for business growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Organ Transplantation Market

The Organ Transplantation Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing Number of Organ Transplantation Surgeries
  • Increasing Prevalence of Chronic Diseases and Accelerating Cases of Organ Failure
  • Development of Legalized Channel for Organ Donors and Transplants
• Market Restraints
  • Shortage of Organ Donors and High Cost of Treatment
• Market Opportunities
  • Technological Advancement in Organ Transplantation Methods
  • Increasing Awareness of Organ Donation
• Market Challenges
  • Social and Ethical Concerns in Organ Transplantation

Porter's Five Forces: A Strategic Tool for Navigating the Organ Transplantation Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Organ Transplantation Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Organ Transplantation Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Organ Transplantation Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Organ Transplantation Market

A detailed market share analysis in the Organ Transplantation Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Organ Transplantation Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Organ Transplantation Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Organ Transplantation Market, highlighting leading vendors and their innovative profiles. These include Illumina, Inc., Veloxis Pharmaceuticals, Inc. by Asahi Kasei Corp., Artivion, Inc., Thermo Fisher Scientific Inc., Pfizer Inc., OrganOx Limited, Organovo Holdings, Inc., Arthrex, Inc., 21st Century Medicine, Exactech, Inc., CHIESI Farmaceutici S.p.A. by Amryt Pharma PLC, Xvivo Perfusion AB, Sanofi S.A., BiolifeSolutions, Inc., Dr. Franz Kohler Chemie GmbH, Teva Pharmaceuticals Industries Ltd., Preservation Solutions, Inc., F. Hoffmann-La Roche Ltd, Organ Recovery Systems, Medtronic PLC, Astellas Pharma Inc., Stryker Corporation, Novartis AG, NHS Blood and Transplant, TransMedics Group, Inc., Plexision, AbbVie Inc., and Bio-Rad Laboratories, Inc..

Market Segmentation & Coverage

This research report categorizes the Organ Transplantation Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Heart Transplantation, Kidney Transplantation, Liver Transplantation, Lung Transplantation, and Pancreas Transplantation.
• Based on End User, market is studied across Hospitals & Care Providers and Transplant Centers.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing Number of Organ Transplantation Surgeries
    • 5.1.1.2. Increasing Prevalence of Chronic Diseases and Accelerating Cases of Organ Failure
    • 5.1.1.3. Development of Legalized Channel for Organ Donors and Transplants
  • 5.1.2. Restraints
    • 5.1.2.1. Shortage of Organ Donors and High Cost of Treatment
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological Advancement in Organ Transplantation Methods
    • 5.1.3.2. Increasing Awareness of Organ Donation
  • 5.1.4. Challenges
    • 5.1.4.1. Social and Ethical Concerns in Organ Transplantation
• 5.2. Market Segmentation Analysis
  • 5.2.1. Type: Burgeoning kidney transplantation due to the increasing incidence of kidney diseases
  • 5.2.2. End User: Evolving organ transplantation in transplant centers owing to the specialization of staff and the technology
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental
• 5.5. Client Customization

6. Organ Transplantation Market, by Type

• 6.1. Introduction
• 6.2. Heart Transplantation
• 6.3. Kidney Transplantation
• 6.4. Liver Transplantation
• 6.5. Lung Transplantation
• 6.6. Pancreas Transplantation

7. Organ Transplantation Market, by End User

• 7.1. Introduction
• 7.2. Hospitals & Care Providers
• 7.3. Transplant Centers

8. Americas Organ Transplantation Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Organ Transplantation Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Organ Transplantation Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
  • 11.3.1. TransMedics Signs Definitive Agreement to Acquire Summit Aviation to Expand TransMedics Aviation Capabilities for Organ Transplantation
  • 11.3.2. LiveOnNY and MediGO Collaborate to Launch Real-Time Organ Tracking Technology to Increase Transparency and Accountability Within the Organ Donation and Transplant Ecosystem
  • 11.3.3. PAHO and Spain Sign Agreement to Strengthen Organ Donation and Transplant in the Americas

Companies Mentioned

• 1. Illumina, Inc.
• 2. Veloxis Pharmaceuticals, Inc. by Asahi Kasei Corp.
• 3. Artivion, Inc.
• 4. Thermo Fisher Scientific Inc.
• 5. Pfizer Inc.
• 6. OrganOx Limited
• 7. Organovo Holdings, Inc.
• 8. Arthrex, Inc.
• 9. 21st Century Medicine
• 10. Exactech, Inc.
• 11. CHIESI Farmaceutici S.p.A. by Amryt Pharma PLC
• 12. Xvivo Perfusion AB
• 13. Sanofi S.A.
• 14. BiolifeSolutions, Inc.
• 15. Dr. Franz Kohler Chemie GmbH
• 16. Teva Pharmaceuticals Industries Ltd.
• 17. Preservation Solutions, Inc.
• 18. F. Hoffmann-La Roche Ltd
• 19. Organ Recovery Systems
• 20. Medtronic PLC
• 21. Astellas Pharma Inc.
• 22. Stryker Corporation
• 23. Novartis AG
• 24. NHS Blood and Transplant
• 25. TransMedics Group, Inc.
• 26. Plexision
• 27. AbbVie Inc.
• 28. Bio-Rad Laboratories, Inc.